74
Participants
Start Date
October 24, 2013
Primary Completion Date
July 29, 2021
Study Completion Date
October 30, 2024
Adavosertib
Given PO
Radiation Therapy
Undergo radiation therapy
Temozolomide
Given PO
Memorial Sloan Kettering Cancer Center, New York
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Wake Forest University Health Sciences, Winston-Salem
University of Alabama at Birmingham Cancer Center, Birmingham
Cleveland Clinic Foundation, Cleveland
Henry Ford Hospital, Detroit
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
UCSF Medical Center-Parnassus, San Francisco
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH